title: Age-associated oxidative damage to the p62 promoter: implications for Alzheimer disease.
abstract: The absence of the p62 gene in mouse brain leads to biochemical and cognitive deficits that resemble Alzheimer disease (AD). In this context, the objective of this study was to examine the relationship between age-induced oxidative damage to the p62 promoter and AD. Increased 8-OHdG staining, a marker of oxidative stress, was observed in brain sections from mice deficient in the p62 gene compared to control. Treatment of MEF cells deficient in p62 with H(2)O(2) resulted in decreased cell survival and an absence of Nrf2 nuclear translocation. The mouse p62 promoter exhibited elevated oxidative damage with increasing age, and the degree of p62 promoter damage was also age-correlated in human brain samples. In human subjects, the expression of p62 was decreased in AD brain relative to age-matched controls, and likewise decreased p62 expression correlated with oxidative damage to the promoter. Treatment of HEK cells with H(2)O(2) resulted in decreased p62 expression concomitant with increased promoter damage. Consistent with these findings, a transgenic AD mouse model also exhibited increased p62 promoter damage and reduced p62 levels in brain. Altogether, our results reveal that oxidative damage to the p62 promoter correlates with decreased expression of p62 and may contribute to age-associated neurodegenerative disease such as AD and others.
authors.affiliation: Cellular and Molecular Biosciences Program, Department of Biological Sciences, Auburn University, AL 38849, USA.
authors.forename: Yifeng
authors.initials: Y
authors.lastname: Du
authors.forename: Michael C
authors.initials: MC
authors.lastname: Wooten
authors.forename: Marla
authors.initials: M
authors.lastname: Gearing
authors.forename: Marie W
authors.initials: MW
authors.lastname: Wooten
mesh_terms: D021581:Active Transport, Cell Nucleus / Q000502:physiology; D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000375:Aging / Q000502:physiology*; D000544:Alzheimer Disease / Q000201:enzymology / Q000235:genetics* / Q000473:pathology; D000818:Animals; D002460:Cell Line; D002470:Cell Survival / Q000502:physiology; D002540:Cerebral Cortex / Q000378:metabolism / Q000473:pathology; D004249:DNA Damage / Q000502:physiology*; D004195:Disease Models, Animal; D005260:Female; D006801:Humans; D008297:Male; D051379:Mice; D018345:Mice, Knockout; D008875:Middle Aged; D051267:NF-E2-Related Factor 2 / Q000502:physiology; D018384:Oxidative Stress / Q000502:physiology*; D011401:Promoter Regions, Genetic; D016271:Proto-Oncogene Proteins c-myc / Q000235:genetics / Q000378:metabolism*; D012307:Risk Factors; D012720:Severity of Illness Index
chemical_list: D051267:NF-E2-Related Factor 2; D016271:Proto-Oncogene Proteins c-myc